Streetbeat News

Regulatory

BTCUSD

Bitcoin (BTC) crossed $37,000 in early Asian trading hours, with nearly $50 million in BTC liquidations reported within a four-hour period. This price surge is attributed to a short squeeze and the SEC's potential approval of 12 separate spot Bitcoin ETFs over the next week. Trading volumes expanded by 57.2% and the market cap increased by 6.4% in the last 24 hours. More than $21 million in shorts were washed away on futures exchanges BitMEX, OKX, and Binance.

Portfolio Pulse from Khyathi Dalal

November 09, 2023 | 3:19 pm

BMY

The U.S. FDA has accepted for priority review Bristol Myers Squibb's application for Breyanzi for relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. The application is based on results from the TRANSCEND CLL 004 trial, which showed clinical benefit with a CAR T cell therapy in heavily pre-treated patients. The FDA has assigned a target action date of March 14, 2024. If approved, Breyanzi would be the first and only CAR T cell therapy available for this patient population.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:14 pm

NIO

NIO's CEO has stated that the company is still considering its entry into the North American market by 2025. The company is open to any kind of partnerships in North America and acknowledges the need to build infrastructure before bringing its electric vehicles to the region.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:50 pm

SPY

Federal Reserve Bank of Atlanta President Raphael Bostic stated that the current monetary policy is likely sufficiently restrictive. This statement may influence the overall market sentiment.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:46 pm

CWBHF

TSX:CWEB

Charlotte's Web Holdings, Inc. reported a 16% YoY decrease in Q3 2023 revenue to $14.3 million, including a drop in direct-to-consumer and business-to-business retail net revenues. The company attributes the decline to regulatory ambiguities and competitive pressures in the CBD market. The company's gross profit was $7.9 million, down from $8.9 million in Q3 2022. The company also reported a net loss of $15.2 million, up from $7.6 million in the same quarter of 2022.

Portfolio Pulse from Jelena Martinovic

November 09, 2023 | 2:37 pm

FXI

NVDA

Nvidia Corp. is set to release three new artificial intelligence chips for China, following the US's further restriction on the Asian nation's access to advanced semiconductors. The chips are based on the design of Nvidia's flagship H100 product. Chinese firms are expected to receive the chips in the coming days. Following the report, Chinese server supplier IEIT Systems Co. saw its stock rise by 10%.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:34 pm

AAPL

Apple Inc. is at risk of losing $14 billion in a tax case at the top European Union (EU) court. An adviser to the court stated that the EU tribunal made legal errors when it ruled in favor of Apple over the tax order and recommended the case be reviewed. The EU had previously claimed that Apple benefited from two Irish tax rulings that artificially reduced its tax burden. The final ruling from the EU Court of Justice is expected in the coming months.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:33 pm

BABA

BIDU

NVDA

Nvidia Corp plans to introduce three new chips in China, despite recent U.S. restrictions on selling advanced AI and gaming chips to Chinese companies. Nvidia has lost significant orders to Huawei and other domestic firms due to these restrictions. However, Nvidia's shares traded higher by 1.83% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

November 09, 2023 | 2:25 pm

ARTL

Artelo Biosciences, Inc. (NASDAQ:ARTL) has announced new research demonstrating the protective properties of its clinical asset, ART27.13, against muscle degeneration caused by certain cancers. The research shows that ART27.13 not only increases appetite in cancer patients but also prevents muscle wasting. The company is currently evaluating ART27.13 in a Phase 2a clinical trial to determine its effect on lean body mass, weight gain, and improvement of anorexia in cancer patients.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:23 pm

AZ

A2Z Smart Technologies Corp. plans to spin off its 80% interest in Advanced Automotive Innovations Inc (AAI). The restructuring will make AAI a publicly traded company, with A2Z shareholders receiving equivalent pro-rata shareholding in AAI. The restructuring is expected to be completed in Q2, 2024. AAI is developing a 'Fuel Tank Inertia Capsule System' designed to prevent fuel combustion in vehicle collisions.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:16 pm